Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for PHARMAZEUTISCHE FORMULIERUNGEN
Details for 2022176524
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2022176524
Title / Product Name
PHARMAZEUTISCHE FORMULIERUNGEN
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2022176524
EP Publication Number
4070787
E-Number
1550521
Language
EN
PCT Number
Publication Date
12.10.2022 A
01.03.2023 B1
Registration Date
01.03.2023
AT Publication Date
15.03.2023
Application Date
29.06.2016
Registration Number
-
Priorities
30.06.2015
US
201562187113 P
22.02.2016
US
201662298373 P
29.02.2016
US
201662301429 P
01.04.2016
US
201662317286 P
IPC
A61K 9/20 20060101AFI20220823BHEP
Maximum Duration of Protection
29.06.2036
Owner
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbH
Schottengasse 3a
1010 Wien
AT
Inventor
KOZIARA, Joanna, M.
Foster City, 94404
US
MCCALLISTER, Scott
Foster City, 94404
US
Information about Fees
Click here to load the fees